Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01379599 · ClinicalTrials.gov registry record · Phase 3
Brief Intervention to Reduce STDs in ER Drug Users
A Phase 3 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,030
- Enrollment target
NCT01379599: Completed Phase 3 study, sponsored by Boston Medical Center.
NCT01379599 is a Phase 3 study that has completed, run by Boston Medical Center. The registered enrollment target is 1,030 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01379599, a Phase 3 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,030 participants
- Enrollment target
Study Summary
The goal of the proposed project is to determine the effectiveness of a brief motivational intervention among Emergency Department (ED) patients who use cocaine and/or heroin to prevent Sexually Transmitted Infections (STIs) and Human Immunodeficiency Virus (HIV) by comparing cumulative incidence and frequency of safe sex behavior between intervention and standard voluntary counseling, testing and referral to substance abuse treatment (control) groups over a one year follow-up period.
Interventions
- BEHAVIORAL brief motivation intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,030 participants |
| Start Date | 2004-11 |
| Est. Completion | 2009-05 |
| Phase | Phase 3 |
What the finished NCT01379599 record still lists
NCT01379599 is an interventional study that assigns participants to a tested intervention. Its 1,030 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% higher).
The record links to 0 conditions, and to 1 intervention - of which brief motivation intervention is the first listed.
NCT01379599 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01379599 about?
NCT01379599 is a clinical study titled "Brief Intervention to Reduce STDs in ER Drug Users". The goal of the proposed project is to determine the effectiveness of a brief motivational intervention among Emergency Department (ED) patients who use cocaine and/or heroin to prevent Sexually Transmitted Infections (STIs) and Human Immunodeficiency Virus (HIV) by comparing cumulative incidence an...
What is the current status of trial NCT01379599?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,030 participants. The study started on 2004-11. Estimated completion is 2009-05.
What interventions are being tested in trial NCT01379599?
The interventions under investigation include: brief motivation intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01379599?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01379599's enrollment target sits among peer trials
1,030 288th of 2000 higher than 1,713 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
- NCT07084363 · 1,032 participants · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
- NCT05037682 · 1,035 participants · NA
Pain and Opioid Management in Older Adults
- NCT07282600 · 1,035 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia